4.6 Article

Effect of methylglyoxal on multidrug-resistant Pseudomonas aeruginosa

Journal

FRONTIERS IN MICROBIOLOGY
Volume 5, Issue -, Pages -

Publisher

FRONTIERS RESEARCH FOUNDATION
DOI: 10.3389/fmicb.2014.00180

Keywords

manuka honey; methylglyoxal; drug efflux system; multidrug resistance; Pseudomonas aeruginosa

Categories

Funding

  1. Japan Society for the Promotion of Science
  2. Kanae Foundation for the Promotion of Medical Science
  3. Senri Life Science Foundation
  4. Government of Japan
  5. Grants-in-Aid for Scientific Research [26713004] Funding Source: KAKEN

Ask authors/readers for more resources

Honey has a complex chemistry, and its broad-spectrum antimicrobial activity varies with floral source, climate, and harvesting conditions. Methylglyoxal was identified as the dominant antibacterial component of manuka honey. Although it has been known that methylglyoxal has antibacterial activity against gram-positive bacteria, including methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus, there is not much information describing its activity against gram-negative bavteria. In this study, we report the effect of methyiglyoxal against multidrug-resistant Pseudomonas aeruginosa (MDRP) using 53 clinically isolated strains. We also assessed the effect of deleting the five multidrug efflux systems in P.aeruginosa, as well as the efflux systems in Escherichia coli and Salmonella enterica serovar Typhimurium, on MICs of methylglyoxal. Our results indicate that methyglyoxal inhibits the growth of MDRP at concentrations of 128-512 mu g/ml (1.7-7.1 mM) and is not recognized by drug efflux systems.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available